Aelis Farma

Developer of small molecule drugs targeting CB1 receptor for CNS diseases

placeBordeaux, Nouvelle Aquitaine, France calendar_todayFounded 2013 groups22 employees language aelisfarma.com

Social engagement

Social engagement: 5.7K social following, 7 posts in the last 12 months — below the industry typical range.

Investor mix

11 investors on record; lead investors include Inserm Transfert, Bpifrance.

Investor typeCountShare
Venture capital218%
Private equity327%
Bank & private debt19%
Other / undisclosed545%

Recent activity

16 Jun 2026
Event
BIO International Convention 2026
21 May 2026
Event
Combined General Meeting 2026
Coming soon